Global Meningococcal Vaccines Market to Reach US$4.4 bn by 2022, Concerns over Increasing Incidence of Meningococcal Infections to Fuel Demand Transparency Market Research (TMR) has recently published a report on the global meningococcal vaccines market, according to which the market is estimated to expand at a healthy CAGR of 12.40% during the period between 2014 and 2022.The research report, titled “Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022,� projects this market to rise from an overall value of US$1.5 bn in 2013 to US$4.4 bn by the end of the forecast period. Meningococcal disease caused by the bacterium Neisseria meningitidis is a life threatening condition which severely infects the meninges or the thin lining surrounding the brain and the spinal cord. Five out of many serogroups of the bacterium are responsible for the invasive meningococcal disease. These serogroups are predominantly present only in humans in the dormant state and may eventually cause the diseased condition due to environmental or immunogenic factors. The disease is known to be contagious and its consequences can be fatal within 24 hours from the onset of symptoms. Prevalence of
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.